Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of RGT-274-CR capsules in adults with obesity
CTR20261326Phase 2Active
- Sponsor
- Regor Therapeutics
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RGT-274 in obesity, sponsored by Regor Therapeutics. Started May 2026; status: active.
02
Drugs
RGT-274
03
Conditions
obesity
Beyond the preview
Go deeper on CTR20261326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261326.